The new Federal Trade Commission chairwoman, Edith Ramirez, has placed the healthcare industry at the top of priorities for the regulator at a meeting attended by antitrust enforcers from around the globe. The decision to focus on healthcare reflects two major cases currently in the hands of the US Supreme Court: the so-called pay-for-delay controversy, and a recent hospital merger in Georgia. The first is expected to see a resolution by July and may change the competition landscape of generic and brand name drug makers. Concerning the hospital merger in Georgia, the Federal Trade Commission recently moved to block a deal where Phoebe Putney Memorial Hospital bought Palmyra Medical Center. The acquisition was completed in 2011 and the case currently before the Supreme Court revolves around whether the local hospital authority, which allowed the merger, trumps federal antitrust law.
Featured News
Saudi Arabia Reviews Uber’s $14.8 Billion Delivery Hero Takeover
Sep 24, 2026 by
CPI
Pope Leo Warns of AI Threats, Calls for Stronger Global Oversight
Sep 24, 2026 by
CPI
Paramount-Warner Bros. Discovery Merger Settlement Faces Coalition Challenge
Sep 24, 2026 by
CPI
New York Grocery Plan Puts Predatory-Pricing Rules to the Test
Sep 24, 2026 by
CPI
Nvidia CEO Opposes Antitrust, Liability Carveouts for AI Firms
Sep 24, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton